1. Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiography
- Author
-
Nneka S. Udechukwu, William H. St. Clair, Shilpa Sachdeva, Kevin P. Landwehr, Hossam Elbelasi, and Michael A. Winkler
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,medicine.medical_specialty ,medicine.medical_treatment ,lcsh:R895-920 ,Brachytherapy ,030232 urology & nephrology ,Case Report ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Embolus ,Recurrent disease ,medicine ,Seed migration ,Radiology, Nuclear Medicine and imaging ,business.industry ,medicine.disease ,Computed tomographic angiography ,medicine.anatomical_structure ,Ventricle ,030220 oncology & carcinogenesis ,Therapeutic seeds ,Radiology ,business ,Prostate brachytherapy - Abstract
Brachytherapy consists of placing radioactive sources into or adjacent to tumors, to deliver conformal radiation treatment. The technique is used for treatment of primary malignancies and for salvage in recurrent disease. Permanent prostate brachytherapy seeds are small metal implants containing radioactive sources of I-125, Pd-103, or Cs-131 encased in a titanium shell. They can embolize through the venous system to the lungs or heart and subsequently be detected by cardiovascular computed tomography. Cardiovascular imagers should be aware of the appearance of migrated seeds, as their presence in the chest is generally benign, so that unnecessary worry and testing are avoided. We report a case of a patient who underwent brachytherapy for prostate cancer and developed a therapeutic seeds embolus to the right ventricle.
- Published
- 2017
- Full Text
- View/download PDF